Virginia hospital deploys Cytyc MammoSite

Virginia Hospital Center in Arlington, Va., is using MammoSite, an accelerated partial breast irradiation (APBI) device, that delivers higher dose radiation therapy to breast cancer patients, from the Marlborough, Mass.-based Cytyc, a Hologic company.

The procedure is used exclusively in women who have undergone breast conservation therapy as opposed to mastectomy. To qualify for APBI, candidates must be 45 years or older with a single, small tumor (less than 3 cm in diameter), no evidence of metastasis, and a tumor cavity that is surrounded by a good margin of healthy tissue, according to the hospital.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.